Glycosylphosphatidylinositol-specific phospholipase D is expressed by macrophages in human atherosclerosis and colocalizes with oxidation epitopes

Circulation

Volumn 99, Issue 22, 1999, Pages 2876-2882

  O'Brien, Kevin D ^a   Pineda, Christine ^a   Chiu, Winnie S ^a   Bowen, Rosario ^b   Deeg, Mark A ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Cells; Enzymes; Proteins

Indexed keywords

EPITOPE; GLYCOSYLPHOSPHATIDYLINOSITOL; PHOSPHOLIPASE D;

ADULT; ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; MACROPHAGE; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

EID: 0033536023     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.22.2876     Document Type: Article

References (43)

1. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94: 2493-2503.
2. Nikkari ST, O'Brien KD, Ferguson M, Hatsukami T, Welgus HG, Alpers CE, Clowes AW. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation. 1995;92:1393-1398.
3. Bornfeldt KE, Campbell JS, Koyama H, Argast GM, Leslie CC, Raines EW, Krebs EG, Ross R. The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. J Clin Invest. 1997;100:875-885.
4. Schwartz SM. Cell death and the caspase cascade. Circulation. 1998;97: 227-229.
5. Seifert PS, Roth I, Schmiedt W, Oelert H, Okada N, Okada H, Bhakdi S. CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesions. Atherosclerosis. 1992;96:135-145.
6. Seifert PS, Hansson GK. Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions. J Clin Invest. 1989;84:597-604.
7. Terry RW, Kwee L, Levine JF, Labow MA. Cytokine induction of an alternatively spliced murine vascular cell adhesion molecule (VCAM) mRNA encoding a glycosylphosphatidylinositol-anchored VCAM protein. Proc Natl Acad Sci U S A. 1993;90:5919-5923.
8. Medof ME, Walter EI, Roberts WL, Haas R, Rosenberry TL. Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid. Biochemistry. 1986;25:6740-6747.
9. Sugita Y, Tobe T, Oda E, Tomita M, Yasukawa K, Yamaji N, Takemoto T, Furuichi K, Takayama M, Yano S. Molecular cloning and characterization of MACIF, an inhibitor of membrane channel formation of complement. J Biochem. 1989;106:555-557.
10. Low MG, Prasad AR. A phospholipase D specific for the phosphatidylinositol anchor of cell-surface proteins is abundant in plasma. Proc Natl Acad Sci U S A. 1988;85:980-984.
11. Davitz MA, Hom J, Schenkman S. Purification of a glycosylphosphatidylinositol-specific phospholipase D from human plasma. J Biol Chem. 1989;264:13760-13764.
12. Deeg MA, Davitz MA. Structure and function of the glycosylphosphatidylinositol-specific phospholipase D. In: Liscovitch M, ed. Signal-Activated Phospholipases. Austin, Tex: R.G. Landes Co; 1994: 125-138.
13. Xie M, Low MG. Expression and secretion of glycosylphosphatidylinositol-specific phospholipase D by myeloid cell lines. Biochem J. 1994;297: 547-554.
14. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
15. Tachado SD, Gerold P, McConville MJ, Baldwin T, Quilici D, Schwarz RT, Schofield L. Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway. J Immunol. 1996;156:1897-1907.
16. Schofield L, Novakovic S, Gerold P, Schwarz RT, McConville MJ, Tachado SD. Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J Immunol. 1996;156:1886-1896.
17. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Tumor necrosis factor gene expression in human vascular intimal smooth muscle cells detected by in situ hybridization. Am J Pathol. 1990;137: 503-509.
18. Moyer CF, Sajuthi D, Tulli H, Williams JK. Synthesis of IL-1α and IL-1β by arterial cells in atherosclerosis. Am J Pathol. 1991;138:951-960.
19. Hoener MC, Brodbeck U. Phosphatidylinositol-glycan-specific phospholipase D is an amphiphilic glycoprotein that in serum is associated with high-density lipoproteins. Eur J Biochem. 1992;206:747-757.
20. Deeg MA. GPI-specific phospholipase D as an apolipoprotein. Braz J Med Biol Res. 1994;27:375-381.
21. Bedossa P, Poynard T, Abella A, Paraf F, Lemaigre G, Martin E. Localization of apolipoprotein A-I and apolipoprotein A-II in human atherosclerotic arteries. Arch Pathol Lab Med. 1989;113:777-780.
22. O'Brien KD, Olin KL, Alpers CE, Chiu W, Ferguson M, Hudkins K, Wight TN, Chait A. Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. Circulation. 1998;98:519-527.
23. Palinski W, Rosenfeld ME, Yla Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989;86:1372-1376.
24. Yla Herttuala S, Rosenfeld ME, Parthasarathy S, Sigal E, Sarkioja T, Witztum JL, Steinberg D. Gene expression in macrophage-rich human atherosclerotic lesions: 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest. 1991;87:1146-1152.
25. O'Brien KD, Alpers CE, Hokanson JE, Wang S, Chait C. Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low density lipoprotein. Circulation. 1996;94:1216-1225.
26. Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 1994;94:437-444.
27. Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation in human coronary arteries. Proc Natl Acad Sci U S A. 1990;87:4600-4604.
28. Böyum A. A one-stage procedure for isolation of granulocytes and lymphocytes from human blood: general sedimentation properties of white blood cells in a 1g gravity field. Scand J Clin Lab Invest Suppl. 1968; 97:51-76.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
30. LeBoeuf RC, Caldwell M, Guo Y, Metz C, Davitz MA, Olson LK, Deeg MA. Mouse glycosylphosphatidylinositol-specific phospholipase D (Glpd1) characterization. Mamm Genome. 1998;9:710-714.
31. Tsang TC, Fung WJ, Levin J, Metz CN, Davitz MA, Burns DK. Isolation and expression of two human glycosylphosphatidylinositol phospholipase D (GPI-PLD) cDNAs. FASEB J. 1992;6:A1922. Abstract.
32. Mendez AJ, Anatharamaiah GM, Segrest JP, Oram JF. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J Clin Invest. 1994;94:1698-1705.
33. Parker LT, Zakeri H, Deng Q, Spurgeon S, Kwok PY, Nickerson DA. AmpliTaq DNA polymerase, FS dye-terminator sequencing: analysis of peak height patterns. Biotechniques. 1996;21:694-699.
34. Xie M, Sesko AM, Low MG. Glycosylphosphatidylinositol-specific phospholipase D is localized in keratinocytes. Am J Physiol. 1993;265: 1156-1168.
35. Deeg MA, Davitz MA. Glycosylphosphatidylinositol-phospholipase D: a tool for glycosylphosphatidylinositol structural analysis. Methods Enzymol. 1995;250:630-640.
36. Brunner G, Metz CN, Nguyen H, Gabrilove J, Patel SR, Davitz MA, Rifkin DB, Wilson EL. An endogenous glycosylphosphatidylinositol-specific phospholipase D releases basic fibroblast growth factor-heparan sulfate proteoglycan complexes from human bone marrow cultures. Blood. 1994;83:2115-2125.
37. Scallon BJ, Fung WJ, Tsang TC, Li S, Kado Fong H, Huang KS, Kochan JP. Primary structure and functional activity of a phosphatidylinositolglycan-specific phospholipase D. Science. 1991;252:446-448.
38. Seidenbecher CI, Richter K, Rauch U, Fassler R, Garner CC, Gundelfinger ED. Brevican, a chondroitin sulfate proteoglycan of rat brain, occurs as secreted and cell surface glycosylphosphatidylinositol-anchored isoforms. J Biol Chem. 1995;270:27206-27212.
39. Ishihara M, Fedarko NS, Conrad HE. Involvement of phosphatidylinositol and insulin in the coordinate regulation of proteoheparan sulfate metabolism and hepatocyte growth. J Biol Chem. 1987;262:4708-4716.
40. Hwang SJ, Ballantyne CM, Sharret AR, Smith LC, Davis CE, Gotto AM Jr, Boerwinkle E. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997;96:4219-4225.
41. Morisaki N, Saito I, Tamura K, Tashiro J, Masuda M, Kanzaki T, Watanabe S, Masuda Y, Saito Y. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Atherosclerosis. 1997;131:43-48.
42. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
43. Chait A, Heinecke JW. Lipoprotein modification: cellular mechanisms. Curr Opin Lipidol. 1994;5:365-370.